🇺🇸 MORAb-009 in United States
3 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 28 March 2025 – 28 March 2026
- Total reports: 3
Most-reported reactions
- Pyrexia — 1 report (33.33%)
- Renal Impairment — 1 report (33.33%)
- Urosepsis — 1 report (33.33%)
Frequently asked questions
Is MORAb-009 approved in United States?
MORAb-009 does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for MORAb-009 in United States?
Morphotek is the originator. The local marketing authorisation holder may differ — check the official source linked above.